Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance
Author:
Funder
H2020 Marie Skłodowska-Curie Actions
Horizon 2020 Framework Programme
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference141 articles.
1. Overcoming endocrine resistance in breast cancer;Hanker;Cancer Cell,2020
2. Chemoresistance caused by the microenvironment of glioblastoma and the corresponding solutions;Zhang;Biomed. Pharmacother.,2019
3. A view on drug resistance in cancer;Vasan;Nature,2019
4. Combination therapy based on nano codelivery for overcoming cancer drug resistance;Wang;Med. Drug Discov.,2020
5. Chemoresistance and the self-maintaining tumor microenvironment;Yeldag;Cancers,2018
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tumor-Homing Peptides as Crucial Component of Magnetic-Based Delivery Systems: Recent Developments and Pharmacoeconomical Perspective;International Journal of Molecular Sciences;2024-06-05
2. Overcoming drug resistance with specific nano scales to targeted therapy: Focused on metastatic cancers;Pathology - Research and Practice;2024-03
3. Autophagy-modulating biomembrane nanostructures: A robust anticancer weapon by modulating the inner and outer cancer environment;Journal of Controlled Release;2024-02
4. Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments;Pharmaceutics;2024-01-26
5. Exploring metal and metal-oxide nanoparticles for nanosensing and biotic stress management in plant systems;Current Research in Biotechnology;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3